Profil
Ludovic Robin served as Deputy Chief Executive Officer at Advicenne SA. He worked at Shire Plc as Marketing Director & Head-Commercial Operations from 2008 to 2016.
Robin also served as Chief Business Officer at PCI Biotech Holding ASA from 2020 to 2022.
He holds an MBA from École des Hautes Études Commerciales de Paris, a doctorate from the University of Lyon, and a graduate degree from Institut de Pharmacie Industrielle de Lyon.
Anciens postes connus de Ludovic Robin
| Sociétés | Poste | Fin |
|---|---|---|
| PCI BIOTECH HOLDING ASA | Corporate Officer/Principal | 01/05/2022 |
| SHIRE | Corporate Officer/Principal | - |
| ADVICENNE | Corporate Officer/Principal | - |
Formation de Ludovic Robin
| École des Hautes Études Commerciales de Paris | Masters Business Admin |
| University of Lyon | Doctorate Degree |
| Institut de Pharmacie Industrielle de Lyon | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| PCI BIOTECH HOLDING ASA | Health Technology |
| ADVICENNE | Health Technology |
| Entreprise privées | 1 |
|---|---|
Shire Plc
 Shire Plc Pharmaceuticals: MajorHealth Technology Shire Plc is a biopharmaceutical company, which engages in the research, development, licensing, manufacturing, marketing, distribution, and sale of medicines. Its products include adderall, advate, adynovate, agrylin, antithrombin 3, aralast, bebulin, buccolam, feiba, firazyr, and foznol. The company was founded in 1986 and is headquartered in Dublin, Ireland. | Health Technology |
